Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Advanced Medical Solutions Group plc (AMS) Ordinary 5p

Sell:228.00p Buy:229.50p 0 Change: 3.50p (1.51%)
FTSE AIM 100:0.46%
Market closed Prices as at close on 18 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:228.00p
Buy:229.50p
Change: 3.50p (1.51%)
Market closed Prices as at close on 18 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:228.00p
Buy:229.50p
Change: 3.50p (1.51%)
Market closed Prices as at close on 18 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials. Its Branded Direct segment is engaged in selling, marketing and innovation of its branded products sold directly by its sales teams. Its Branded Distributed segment is engaged in distribution, marketing and innovation of its brands sold by distributors in markets not serviced by its sales team. Its OEM segment is engaged in selling, marketing and innovation of its products supplied to partners under their brands. Its Bulk Materials segment is engaged in selling, marketing and innovation of bulk materials to medical device partners and convertors. Its products include ActivHeal, LiquiBand and RESORBA.

Contact details

Address:
Premier Park, 33 Road One
WINSFORD
CW7 3RT
United Kingdom
Telephone:
+44 (01606) 863500
Website:
https://www.admedsol.com/

Important dates

Future events
Interim dividend payment date 23 October 2020 23/10/20
Interim ex-dividend date 24 September 2020 24/09/20
Past events
Interim results 16 September 2020 16/09/20
Trading Announcement 09 July 2020 09/07/20
Final dividend payment date 19 June 2020 19/06/20
Trading Announcement 10 June 2020 10/06/20
AGM 10 June 2020 10/06/20
Final ex-dividend date 28 May 2020 28/05/20
Final results 11 March 2020 11/03/20
Drilling report 11 March 2020 11/03/20
Trading Announcement 15 January 2020 15/01/20
Interim dividend payment date 25 October 2019 25/10/19
Interim ex-dividend date 26 September 2019 26/09/19

General stock information

EPIC:
AMS
ISIN:
GB0004536594
Market cap:
£490.83 million
Shares in issue:
215.28 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE AIM 100,FTSE AIM All Share

Key personnel

  • Andrew Meredith
    Group Chief Executive Officer, Executive Director
  • Eddie Johnson
    Chief Financial Officer, Executive Director, Company Secretary
  • Alan Richardson
    Chief Operating Officer
  • Cathy Tomlinson
    Group Human Resources Director
  • Simon Coates
    Group Manager - IS
  • Rose Guang
    Director - Group Quality Assurance/Regulatory Affairs (QA/RA)
  • Pieter Van-Hoof
    Director - Group Operations
  • Becky Walmsley
    Business Unit Director - Woundcare
  • Jeffrey Willis
    Business Unit Director - Surgical

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.